Apellis Pharmaceuticals to Present at Upcoming Investor Conferences

Rhea-AI Summary

Apellis Pharmaceuticals (Nasdaq: APLS) has announced its participation in two upcoming investor conferences. The first is the 5th Annual Evercore ISI HealthCONx Conference, featuring a fireside chat scheduled for November 29, 2022, at 8:25 a.m. ET. The second is the Bank of America 2022 Virtual Biotech SMID Cap Conference, set for December 7, 2022, at 9:40 a.m. ET. Both events will be accessible via live webcast on the company's website, with replays available for 90 days.

WALTHAM, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) --  Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced that the company will participate in the following investor conferences:

• 5^th Annual Evercore ISI HealthCONx Conference: Fireside chat on Tuesday, November 29, 2022, at 8:25 a.m. ET.
• Bank of America 2022 Virtual Biotech SMID Cap Conference: Fireside chat on Wednesday, December 7, 2022, at 9:40 a.m. ET.

Each conference event will be available via a live webcast from the “Events and Presentations” page of the “Investors and Media” section of the company’s website. A replay of the webcasts will be available for 90 days following the event.

About Apellis 
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is committed to leveraging courageous science, creativity, and compassion to deliver life-changing therapies. Leaders in complement, we ushered in the first new class of complement medicine in 15 years with the approval of the first and only targeted C3 therapy. We are advancing this science to continually develop transformative medicines for people living with rare, retinal, and neurological diseases. For more information, please visit http://apellis.com or follow us on Twitter and LinkedIn.

Investor Contact:
Meredith Kaya
meredith.kaya@apellis.com
617.599.8178

FAQ

What is Apellis Pharmaceuticals planning to present at the 5th Annual Evercore ISI HealthCONx Conference?

Apellis Pharmaceuticals will hold a fireside chat on November 29, 2022, at 8:25 a.m. ET during the conference.

When is the Bank of America 2022 Virtual Biotech SMID Cap Conference?

The Bank of America 2022 Virtual Biotech SMID Cap Conference is scheduled for December 7, 2022, at 9:40 a.m. ET.

Where can I watch the presentations from Apellis Pharmaceuticals' investor conferences?

The presentations will be available via live webcast on the 'Events and Presentations' page of Apellis Pharmaceuticals' website.

Will there be replays available for the Apellis Pharmaceuticals conference webcasts?

Yes, replays of the webcasts will be available for 90 days following each event.

What is the stock symbol for Apellis Pharmaceuticals?

The stock symbol for Apellis Pharmaceuticals is APLS.